 |
Market Research Report
Restricted Access Barrier Systems (RABS) Market with COVID-19 Impact Analysis, By Product Type, By End-user, and By Region - Size, Share, & Forecast from 2021-2027 |
||||||
| Published by | AnalystView Market Insights | Product code | 970084 | ||||
| Published | Content info | 210 Pages Delivery time: 2-3 business days |
|||||
| Price |
|
||||||
| Restricted Access Barrier Systems (RABS) Market with COVID-19 Impact Analysis, By Product Type, By End-user, and By Region - Size, Share, & Forecast from 2021-2027 | ||
| Published: November 1, 2020 | Content info: 210 Pages |
|
The global restricted access barrier systems (RABS) market was valued at USD XXX billion by 2019, growing with XX.X% CAGR during the forecast period, 2021-2027.
Restricted access barrier systems (RABS) protects from contamination and offers a high level of product protection. This system is used in a combination of physical and aerodynamic barriers, unlike isolators. They prevent access of contaminants into the interior environment. The physical barrier is embedded with glass or polycarbonate doors with stainless steel walls similar to machine guarding, that fully enclose the machinery with an air handler delivering HEPA filtered, unidirectional airflow providing an ISO 5 environment. For instance, according to the Society for Pharmaceutical Engineering (ISPE) guidelines, RABS should provide an airflow of ISO5. Further, it should also provide a physical barriers in the critical zone for human interventions. In the pharmaceutical and medical industry, maintaining aseptic conditions is of utmost importance in order to protect the product from contamination. Thus, this feature is provided by cleanrooms, but in maximum cases, these suffer high capital.
Delivery of aseptic safety in the critical zone of an isolator and flexibility for interferences like cleanroom is expected to rise the demand for the RABS system throughout the forecast period. Stringent rules and regulations for manufacturing procedures for efficient and aseptic medical and pharmaceutical products coupled with the rising manufacturing from toxic and viral product agents and the need for safety in research and development are projected to fuel restricted access barrier systems (RABS) market demand in the coming years. Furthermore, efficiency and lower capital investment compared to the cleanroom and isolator are anticipated to drive business for restricted access barrier systems in the near-decade. Increasing demand for aseptic and efficient pharmaceutical products, and rising need for safety in research and development and manufacturing from toxic and viral product agents will support the restricted access barrier systems market growth in near future. On the other hand, the high cost of maintenance and installation is predicted to restrain the growth of the overall restricted access barrier systems (RABS) market. In addition, a lack of trained operators and a limited number of suppliers might pose a challenge for business growth.
Depending upon the type, the passive RABS segment dominates the target market. This segment uses purified and filtered air from the cleanroom. Passive RABS does not have its own air conditioning system and air filters. Active RABS contains a HEPA filter to provide filtered air-flow distribution in a critical areas. The segment is further subdivided in terms of the outlet into open RABS and closed RABS. The availability of major biotechnology and pharmaceutical organizations and demand for aseptic, safe, and standard research and manufacturing processes are influencing the growth of the global restricted access barrier systems (RABS) market worldwide.
Key features of the study:
This proposed research study on Restricted Access Barrier Systems (RABS) market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2020-2027), considering 2019 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Restricted Access Barrier Systems (RABS) market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Restricted Access Barrier Systems (RABS) market
Impact of COVID-19 on Restricted Access Barrier Systems (RABS) market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Restricted Access Barrier Systems (RABS) market post-COVID will also be covered.
In order to give the users of this report a comprehensive view on the Restricted Access Barrier Systems (RABS) market, we have also included competitive landscape and key innovator analysis for the Restricted Access Barrier Systems (RABS) market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and End-user's attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Restricted Access Barrier Systems (RABS) market.
In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new Product Type launch, research & development, regional expansion of major participants involved in the Restricted Access Barrier Systems (RABS) market on global as well as regional level.
The global Restricted Access Barrier Systems (RABS) market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL RESTRICTED ACCESS BARRIER SYSTEMS (RABS) MARKET KEY PLAYERS
IMA S.p.A.
S.L.U.
Comecer S.p.A.
Extract Technology
Robert Bosch GmbH
Ortner Reinraumtechnik GmbH
Germfree
AZBIL TELSTAR
Tofflon Science and Technology Co., Ltd.
Isolation Systems, Inc.
GLOBAL RESTRICTED ACCESS BARRIER SYSTEMS (RABS) MARKET, BY PRODUCT TYPE
Passive RABS
Active RABS
GLOBAL RESTRICTED ACCESS BARRIER SYSTEMS (RABS) MARKET, BY END-USER
Pharmaceutical
Medical
Chemical
Electrical Engineering
Others
GLOBAL RESTRICTED ACCESS BARRIER SYSTEMS (RABS) MARKET, BY REGION
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Singapore
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Rest of MEA
List of Tables
List of Figures
